Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
224 studies found for:    Open Studies | "Ear Diseases"
Show Display Options
Rank Status Study
21 Recruiting Pilot Project on External Vestibular Prosthesis in Chronic Subjective Dizziness
Condition: Dizziness Chronic
Intervention: Device: Balance Belt
22 Recruiting Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype
Conditions: Neurofibromatosis;   Neurofibromatosis I;   Neurofibromatosis 2;   Schwannomatosis
Intervention: Behavioral: The Relaxation Response Resiliency Program (3RP) via Skype
23 Recruiting Protective Effects of EPI-743 on Noise-Induced Hearing Loss
Condition: Noise-induced Hearing Loss
Interventions: Drug: EPI-743;   Drug: Placebo
24 Not yet recruiting SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss
Conditions: Lung Cancer;   Head and Neck Cancer;   Hearing Loss;   Ototoxicity;   Tinnitus;   Neuropathy
Interventions: Drug: SPI-1005 Low Dose;   Drug: SPI-1005 Middle Dose;   Drug: SPI-1005 High Dose;   Drug: Placebo
25 Recruiting Observation of Benefits for Patients Implanted With a Hearing Implant of the Company Cochlear
Condition: Hearing Loss
Intervention: Device: Cochlear® Hearing Implants
26 Recruiting Clinical and Genetic Examination of Usher Syndrome Patients' Cohort in Europe
Condition: Usher Syndrome
Intervention:
27 Recruiting Study of Oculomotor Dysfunction Leading to Children Vertigo
Conditions: Vertigo;   Headache;   Anomaly of Vergence System;   Accommodation Disorders;   Orthoptic Rehabilitation
Interventions: Procedure: orthoptic rehabilitation;   Other: Orthoptic diagnostic
28 Not yet recruiting Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma
Conditions: Vestibular Schwannoma;   Meningioma;   Acoustic Neuroma;   Neurofibromatosis Type 2
Intervention: Drug: AR-42
29 Unknown  Phase III Open Study, Prospective, Multicenter, Randomized, Comparative to the Positive Control for Evaluating the Efficacy and Safety of Auris-Sedina in the Symptomatic Control of Otalgy in Patients With or Without Acute External Otitis.
Conditions: Otitis;   Efficacy;   Tolerability
Interventions: Drug: Auris-Sedina;   Drug: Otosynalar®
30 Not yet recruiting Acoustic Stimulation Paired With Body and Cortical Stimulation for Modulating Tinnitus
Condition: Tinnitus
Interventions: Device: noise sound stimulation (Tucker-Davis Technologies);   Device: body electrical stimulation (Digitimer device);   Device: transcranial magnetic stimulation (Magstim)
31 Recruiting Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts
Conditions: Sensorineural Hearing Loss;   Cytomegalovirus Infection
Intervention:
32 Recruiting Phenotypic and Genotypic Identification and Characterization of MYH9-related Constitutional Thrombocytopenia
Conditions: May-Hemalin;   Fechtner Syndrome (Disorder);   Epstein Syndrome (Disorder);   MYH9 Related Disorders
Intervention:
33 Not yet recruiting Benefits of the HiResolutionTM Bionic Ear System in Adults With Low-Frequency Hearing
Condition: Severe-to-profound Hearing Loss
Intervention: Other: Observational study
34 Recruiting Study Using Dexmedetomidine to Decreases Emergence Delirium in Pediatric Patients
Condition: Otitis Media
Interventions: Drug: dexmedetomidine;   Drug: saline
35 Recruiting Effectiveness of P02 Digital Hearing Aids
Conditions: Hearing Loss, Bilateral;   Sensorineural Hearing Loss
Intervention: Procedure: Hearing Aids Evaluation
36 Recruiting Latanoprost for the Treatment of Menière's Disease
Condition: Menière's Disease
Interventions: Drug: Latanoprost;   Other: Placebo
37 Unknown  The Phonak EduLink-System in Students With Specific Performance Deficits in Speech-in-Noise Intelligibility
Condition: Auditory Processing Disorder
Intervention: Device: hearing aid, Phonak EduLink-FM System
38 Recruiting Daily Bi-temporal Transcranial Random Noise Stimulation in Tinnitus
Condition: Chronic Tinnitus
Intervention: Device: Transcranial random noise stimulation (tRNS)
39 Not yet recruiting Congenital CMV and Hearing Loss in Children up to 4 Years of Age: Treating With Valganciclovir Therapy
Conditions: Congenital Cytomegalovirus;   Hearing Loss
Interventions: Drug: Valcyte (Valganciclovir hydrochloride) Powder for oral solution;   Drug: Placebo
40 Recruiting Non-Syndrome Hereditary Hearing Impairment - Gene Mapping: India/Pakistan Protocol
Condition: Hearing Impairment
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years